Human medicines
GA-67-MM-1
The marketing authorization holder, in consultation with the French authority, informed its supplied customers by letter dated 10/10/2012 that batch…
Typhim-Vi
Sanofi Pasteur MSD GmbH has informed its supplied customers in a letter dated 24.09.2012 that a voluntary recall is being carried out for the…
Truvada
The parallel distributor, HAEMATO PHARM AG; has informed its supplied customers by letter dated 5.9.2012 that the batches placed on the market by him…
Carmubris (Ben Venue)
The marketing authorization holder informed its supplied customers in a letter dated August 27, 2012, that in the course of stability tests at the…
Thymoglobulin
The distribution partner sanofi-aventis GmbH Austria informed its supplied customers by letter dated August 13, 2012, that aggregates above the…
Directions for use Ropivacaine
Misleading wording in package insert, see related file.
Package Leaflet Mitomycin
Packaged finished product batches as of May 2011 contain incorrect information in the package insert, see associated file.
Allergovit
The marketing authorization holder informed its customers by letters dated July 10 and 13, 2012, that the patient-specific batches could have an…
Effortil comp. drops
The marketing authorization holder informed its supplied customers in a letter dated July 2, 2012, that quality deviations were detected in current…
Propofol
The marketing authorization holder informed its supplied customers by letter dated 28.06.2012 that the transport carton of batch A010816 is labeled…
